Table 1 Overall mortality and mortality rate ratios at diagnosis/index date for soft tissue sarcoma patients (N = 1246) and the general comparison cohort (N = 6230)

0 to 5 years

Gender

Female

40.2 (36.4-44.3)

10.7 (9.7-11.9)

4.8 (4.1-5.7)

4.7 (3.9-5.6)

Male

41.6 (37.9-45.5)

13.5 (12.4-14.7)

3.9 (3.4-4.6)

4.2 (3.6-4.9)

Age (years)

0-39

27.2 (22.5-32.7)

0.3 (0.1-0.7)

116.7 (42.7-318.6)

110.8 (40.5-303.0)

40-59

24.4 (20.3-29.2)

2.4 (1.8-3.3)

11.5 (8.0-16.4)

11.0 (7.6-15.8)

60-79

53.9 (49.5-58.5)

16.5 (15.1-18.1)

4.7 (4.0-5.5)

4.4 (3.7-5.1)

≥ 80

72.2 (64.3-79.6)

51.2 (47.4-55.1)

1.9 (1.5-2.4)

1.9 (1.5-2.4)

Comorbidity

None

34.9 (31.9-38.0)

7.0 (6.3-7.8)

6.2 (5.4-7.2)

6.6 (5.7-7.7)

Low

52.3 (43.3-62.0)

24.3 (21.2-27.8)

2.9 (2.1-3.9)

3.0 (2.2-4.1)

Moderate

60.6 (51.5-69.7)

34.2 (29.7-39.2)

2.5 (1.9-3.4)

2.8 (2.1-3.8)

High

68.7 (58.8-78.2)

48.9 (43.0-55.3)

1.8 (1.3-2.4)

2.0 (1.4-2.7)

Total

41.0 (38.3-43.7)

12.2 (11.4-13.0)

4.3 (3.8-4.8)

4.4 (3.9-4.9)

5 to 10 years

Gender

Female

16.0 (12.3-20.6)

11.7 (10.4-13.1)

1.4 (1.1-2.0)

1.8 (1.3-2.5)

Male

19.2 (15.4-23.9)

15.2 (13.8-16.7)

1.3 (1.0-1.7)

1.5 (1.2-2.0)

Age (years)

0-39

8.1 (5.1-13.0)

0.8 (0.4-1.4)

11.1 (5.1-24.6)

11.1 (5.0-24.6)

40-59

12.4 (8.8-17.3)

4.4 (3.5-5.6)

3.1 (2.0-4.8)

2.9 (1.8-4.4)

60-79

28.4 (22.3-35.8)

24.3 (22.2-26.5)

1.2 (0.9-1.6)

1.2 (0.9-1.6)

≥ 80

60.0 (42.8-77.7)

64.0 (57.9-70.0)

1.0 (0.6-1.7)

1.1 (0.7-1.7)

Comorbidity

None

13.7 (11.1-16.9)

11.1 (10.1-12.2)

1.4 (1.1-1.8)

1.5 (1.2-2.0)

Low

41.3 (26.5-60.4)

23.0 (18.8-27.9)

1.3 (0.8-2.3)

1.6 (0.9-2.8)

Moderate

44.9 (30.6-62.3)

23.9 (19.9-28.6)

1.9 (1.1-3.3)

2.8 (1.6-4.9)

High

32.9 (17.8-55.7)

20.1 (15.6-25.6)

0.7 (0.3-1.5)

0.9 (0.4-2.0)

Total

17.7 (14.9-20.9)

13.5 (12.5-14.5)

1.4 (1.1-1.7)

1.6 (1.3-2.0)